|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
1998-12-24
|
|
pubmed:abstractText |
Adolescents with conduct disorder (CD) and substance use disorders (SUD) have higher rates of comorbid attention-deficit/hyperactivity disorder (ADHD) than those without CD and SUD. Comorbid ADHD may contribute to more severe SUD. Treatment of ADHD may enhance effective treatment of substance abuse and behavior problems, yet there are few data regarding pharmacological treatment of ADHD in such youths.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0890-8567
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1271-8
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9847499-Adolescent,
pubmed-meshheading:9847499-Attention Deficit Disorder with Hyperactivity,
pubmed-meshheading:9847499-Bupropion,
pubmed-meshheading:9847499-Conduct Disorder,
pubmed-meshheading:9847499-Dopamine Uptake Inhibitors,
pubmed-meshheading:9847499-Humans,
pubmed-meshheading:9847499-Male,
pubmed-meshheading:9847499-Pilot Projects,
pubmed-meshheading:9847499-Statistics, Nonparametric,
pubmed-meshheading:9847499-Substance-Related Disorders
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder.
|
|
pubmed:affiliation |
Department of Psychiatry, University of Colorado School of Medicine, Denver, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.
|
